Spots Global Cancer Trial Database for gmg
Every month we try and update this database with for gmg cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Evaluation of Pharmacokinetics, Pharmacodynamics, Efficacy, Safety, and Immunogenicity of Ravulizumab Administered Intravenously in Pediatric Participants With Generalized Myasthenia Gravis (gMG) | NCT05644561 | Generalized Mya... gMG | Ravulizumab | - | Alexion Pharmaceuticals, Inc. | |
| Evaluation of Pharmacokinetics, Pharmacodynamics, Efficacy, Safety, and Immunogenicity of Ravulizumab Administered Intravenously in Pediatric Participants With Generalized Myasthenia Gravis (gMG) | NCT05644561 | Generalized Mya... gMG | Ravulizumab | - | Alexion Pharmaceuticals, Inc. | |
| A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis | NCT03971422 | Generalized Mya... | Rozanolixizumab Placebo | 18 Years - | UCB Pharma | |
| An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis | NCT06435312 | Generalized Mya... | Zilucoplan | 12 Years - | UCB Pharma | |
| An Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Zilucoplan in Participants With Generalized Myasthenia Gravis Who Were Previously Receiving Intravenous Complement Component 5 Inhibitors | NCT05514873 | Generalized Mya... | zilucoplan (RA1... | 18 Years - 85 Years | UCB Pharma | |
| Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis | NCT05218096 | Generalized Mya... Myasthenia Grav... | ALXN2050 Placebo | 18 Years - 130 Years | Alexion Pharmaceuticals, Inc. | |
| Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis | NCT05218096 | Generalized Mya... Myasthenia Grav... | ALXN2050 Placebo | 18 Years - 130 Years | Alexion Pharmaceuticals, Inc. | |
| A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis | NCT06055959 | Generalized Mya... | Zilucoplan | 12 Years - 17 Years | UCB Pharma | |
| A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis | NCT04124965 | Generalized Mya... | Rozanolixizumab | 18 Years - | UCB Pharma | |
| A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis (gMG) | NCT05681715 | Generalized Mya... | Rozanolixizumab | 18 Years - | UCB Pharma | |
| Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs) | NCT04202341 | Generalized Mya... | - | Alexion Pharmaceuticals, Inc. | ||
| A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis | NCT06149559 | Generalized Mya... | rozanolixizumab | 2 Years - 17 Years | UCB Pharma | |
| A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis | NCT04650854 | Generalized Mya... | Rozanolixizumab | 18 Years - | UCB Pharma | |
| Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG) | NCT04146051 | Myasthenia Grav... | Descartes-08 | 18 Years - | Cartesian Therapeutics | |
| A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis | NCT06055959 | Generalized Mya... | Zilucoplan | 12 Years - 17 Years | UCB Pharma | |
| A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis | NCT06149559 | Generalized Mya... | rozanolixizumab | 2 Years - 17 Years | UCB Pharma |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
